December 12 to December 15, 2016 WIPO’s Page on the Meeting SCP 25: Opening statement of Knowledge Ecology International SCP25: Statement of Asia Pacific Group on Patents and Health SCP25: South Africa’s Experience Related to the Topic of Access to… Continue Reading
On Thursday, 15 December 2016, South Africa delivered this poignant, closing statement at WIPO’s Standing Committee on the Law of Patents (SCP). Negotiations broke down on the issue of future work, as the European Union and Group B refused to permit discussions of the Report of the UN Secretary-General’s High-Level Panel on Access to Medicines at future sessions of the SCP.
According to the WIPO website,
On Wednesday, 14 December 2016, the delegation of South Africa delivered a comprehensive, moving account of South Africa’s “journey in the quest to provide access to essential medicines” at WIPO’s Standing Committee on the Law of Patents.
South Africa Access to Medicines: South Africa’s Experience Related to the Topic of Access to Medicines at the Standing Committee on the Laws of PatentsBackground
Madam Vice Chair,
SCP25: Statement of Asia Pacific Group on Patents and Health
On Tuesday, 13 December 2016, India delivered the following statement on behalf of the Asia and the Pacific Group during WIPO discussions on patents and health.
Statement by India on behalf of the Asia and the Pacific Group on the Agenda Item – Patents and Health – delivered by Dr. Sumit Seth, First Secretary (Economic Affairs) on 13 December 2016Madam Chair,
India has the honour to deliver this statement on behalf of the Asia Pacific Group. The group would like to make 3 concrete points related to this agenda item
SCP 25: Opening statement of Knowledge Ecology International
On Monday, 12 December 2016, Knowledge Ecology International (KEI) delivered its opening statement to the 25th session of WIPO’s Standing Committee on the Law of Patents (SCP).
KEI Opening Statement, for SCP 25
12 December 2016KEI will discuss two topics. The first concerns government rights in patented inventions, when the government funds or partly funds the research.